2011 clinical practice guidelines for type 2 diabetes in Korea
about
Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statementThe Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Understanding How Data Can Inform Clinical Practice in KoreaLow pulmonary function in individuals with impaired fasting glucose: the 2007-2009 Korea national health and nutrition examination surveyDevelopment of an HbA1c-based conversion equation for estimating glycated albumin in a Korean population with a wide range of glucose intoleranceThe relationship between BMI and glycated albumin to glycated hemoglobin (GA/A1c) ratio according to glucose tolerance statusComparison between the therapeutic effect of metformin, glimepiride and their combination as an add-on treatment to insulin glargine in uncontrolled patients with type 2 diabetesFasting plasma glucose concentrations for specified HbA1c goals in Korean populations: data from the Fifth Korea National Health and Nutrition Examination Survey (KNHANES V-2, 2011)Feasibility of a Patient-Centered, Smartphone-Based, Diabetes Care System: A Pilot Study.Internet-based mentoring program for patients with type 1 diabetes.Patterns, control and complications of diabetes from a hospital based registry established in a low income countryCurrent status of prescription in type 2 diabetic patients from general hospitals in busan.Association of vitamin B12 deficiency and metformin use in patients with type 2 diabetes.Higher prevalence of metformin-induced vitamin B12 deficiency in sulfonylurea combination compared with insulin combination in patients with type 2 diabetes: a cross-sectional studyThe association between chronic kidney disease and diabetic retinopathy: the Korea National Health and Nutrition Examination Survey 2008-2010.Assessment of glycemic control in patients with type 2 diabetes mellitus treated with metformin-sulfonylurea combination: Results of a multicenter, cross-sectional, observational study in KoreaAssociation between Self-Reported Smoking and Hemoglobin A1c in a Korean Population without Diabetes: The 2011-2012 Korean National Health and Nutrition Examination Survey.Low Density Lipoprotein Cholesterol Target Goal Attainment Rate and Physician Perceptions about Target Goal Achievement in Korean Patients with DiabetesThe glycemic efficacies of insulin analogue regimens according to baseline glycemic status in Korean patients with type 2 diabetes: sub-analysis from the A(1)chieve(®) study.Body mass index and waist circumference according to glucose tolerance status in Korea: the 2005 Korean Health and Nutrition Examination Survey.Current Status of Management in Type 2 Diabetes Mellitus at General Hospitals in South KoreaEfficacy of a New Medical Information system, Ubiquitous Healthcare Service with Voice Inception Technique in Elderly Diabetic PatientsThe risk of bladder cancer in korean diabetic subjects treated with pioglitazone.Relationship between metabolic syndrome and thyroid nodules in healthy KoreansClinical Characteristics of Subjects with Sulfonylurea-Dependent Type 2 Diabetes.Smoking and type 2 diabetes mellitusGlycosylated Hemoglobin Threshold for Predicting Diabetes and Prediabetes from the Fifth Korea National Health and Nutrition Examination Survey.Association between estimated blood glucose levels and glycated hemoglobin levels.Severe Hypoglycemia and Cardiovascular or All-Cause Mortality in Patients with Type 2 Diabetes.Metabolic syndrome independently predicts future diabetes in women with a history of gestational diabetes mellitusPrevalence of Diabetes and Prediabetes according to Fasting Plasma Glucose and HbA1c.Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002-2013: Nationwide population-based cohort study.Optimal Glycemic and Hemoglobin A1c Thresholds for Diagnosing Diabetes Based on Prevalence of Retinopathy in an Iranian Population.A Potential Issue with Screening Prediabetes or Diabetes Using Serum Glucose: A Delay in Diagnosis.Metformin based dual-combination therapies in drug naïve type 2 diabetic patients.Glycemic Effectiveness of Metformin-Based Dual-Combination Therapies with Sulphonylurea, Pioglitazone, or DPP4-Inhibitor in Drug-Naïve Korean Type 2 Diabetic Patients.Efficient Strategy to Identify Gene-Gene Interactions and Its Application to Type 2 Diabetes.Plasma glucose regulation and mortality in Korea: a pooled analysis of three community-based cohort studies.Higher prevalence and awareness, but lower control rate of hypertension in patients with diabetes than general population: the fifth korean national health and nutrition examination survey in 2011.Avoiding or coping with severe hypoglycemia in patients with type 2 diabetes.Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review.
P2860
Q26783199-FFB9F400-4225-4B00-AB3F-E2BE84FDCE95Q26852590-3E0C0BBE-78FD-4ABC-96C8-ABDDE632DA65Q28389180-7D65878C-E682-4E8E-BD91-BB3F502687A4Q28538120-8BF89019-ED88-475C-8FBF-74E592FC5DBAQ28540239-0B314133-4AA4-4243-851B-90590233B48EQ28540655-10A01C53-2AC4-49CD-AF20-C42D730D965BQ31125771-C2C85BD5-02A7-4BF1-A52A-F59FFBB74BABQ33448350-A4CD3491-4CC5-4DEC-8A56-D405AED7FAE0Q33612496-174325B3-17F5-419F-8C0C-1B19F6737F4DQ33768201-8829858F-094B-46B8-82BD-7343E1384195Q33850338-4E71D541-2991-4C63-8F81-442D9A90927AQ33913744-C36B8BB1-D902-417D-9AE8-94C97ACED09EQ34317618-B11433ED-599E-4BF5-BD6B-2CA9C84E1532Q35301427-57222FF2-1C88-4F36-9B9C-A6CF3EE6F2A0Q35571835-9BB8A8EE-72D4-4E4A-968E-6BD52616EDCDQ35642055-0065F37F-3268-473B-B1F5-34120A32B88AQ35661451-FB94DEDC-A24B-4557-8D37-7B33E821E548Q35817211-DFDAD1CB-A570-496F-A703-4554F0A31A1BQ35928991-3B8E11BF-617F-4766-91B9-E69E87E6ABCCQ35976468-C06D09D9-8159-4416-A3E5-C2E93F5FCB70Q36363903-81A7D28B-5604-475E-9F22-4FAF991978AEQ36365241-8DD9DBA8-D294-4736-80E1-6799B230F284Q36461174-A25CE171-3597-4F53-8350-C95879F1ACBFQ36489150-171B90F3-F847-4FB7-BBDD-C79E05CBFB18Q36490115-5A7D08B6-BE56-485C-B148-102653D4721DQ36858488-50D08300-3139-47D6-B258-021459319E36Q36864521-E1E00157-9347-4703-BE92-7CD9CB887135Q37056836-AAB26F3F-3887-4A6D-80C8-3EC1BE2C0677Q37226211-3843A2FD-20D5-4DB3-AF7B-28F46351EB56Q37275527-D31AAF14-571E-4E27-9D89-75219B823F50Q37327943-54EDE271-6716-4B20-9B7C-8D239FB96129Q37342171-FA73BC5B-DD93-479A-96B2-F89045D635ABQ37348608-E42CD437-69E4-4295-9732-F184257C4295Q37435700-11F282A8-4F60-4486-8A51-948C325013F9Q37435728-DB3523AC-FF79-413E-B48E-7ABB36EA40D6Q37618971-CD5F4CAB-DF8D-413B-810A-B53C6B21E450Q37630970-0FCF62E7-03DD-4394-90C1-934BD505D0E2Q37630972-5533B477-E442-44BF-891D-6C3FFDAA589FQ38318796-20243E3D-029D-4FCF-B39F-EC785F662943Q38563239-EEA2095D-2047-4454-96FA-8F8E55499759
P2860
2011 clinical practice guidelines for type 2 diabetes in Korea
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
2011 clinical practice guidelines for type 2 diabetes in Korea
@ast
2011 clinical practice guidelines for type 2 diabetes in Korea
@en
type
label
2011 clinical practice guidelines for type 2 diabetes in Korea
@ast
2011 clinical practice guidelines for type 2 diabetes in Korea
@en
prefLabel
2011 clinical practice guidelines for type 2 diabetes in Korea
@ast
2011 clinical practice guidelines for type 2 diabetes in Korea
@en
P2093
P2860
P1476
2011 clinical practice guidelines for type 2 diabetes in Korea
@en
P2093
Chong Hwa Kim
Committee of Clinical Practice Guidelines, Korean Diabetes Association
Dong-Joon Kim
Eun-Kyung Hong
Hae Jin Kim
Hye-Jin Lee
Jae-Hyoung Cho
Jae-Taik Kim
Jun-Young Kim
P2860
P304
P356
10.4093/DMJ.2011.35.5.431
P577
2011-10-31T00:00:00Z